{"transactions":[{"id":4084579,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":169966,"kind":"person","name":"Trucksis Michele","position":1,"cik":"0001643736","reported_name":"Trucksis Michele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"STOCK OPTION (RIGHT TO BUY)","published_at":"2018-01-31T01:58:24.000Z","date":"2018-01-30","kind":"grant","acquired":false,"shares":95000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Option will vest as to 25% of the shares on January 30, 2019.  The remainder of the shares will vest in 12 equal quarterly installments thereafter."}],"balance_after":95000,"derivative":{"exercise_price":10.42,"expiration_date":"2028-01-29","underlying":"COMMON STOCK","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0000899243-18-002328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924318002328/doc4.xml","form_type":"4"}},{"id":4084578,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":169966,"kind":"person","name":"Trucksis Michele","position":1,"cik":"0001643736","reported_name":"Trucksis Michele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"RESTRICTED STOCK UNITS","published_at":"2018-01-31T01:58:24.000Z","date":"2018-01-26","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019; and 50% on January 26, 2020."}],"balance_after":30000,"derivative":{"underlying":"COMMON STOCK","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0000899243-18-002328","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924318002328/doc4.xml","form_type":"4"}},{"id":4084577,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":169966,"kind":"person","name":"Trucksis Michele","position":1,"cik":"0001643736","reported_name":"Trucksis Michele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK","published_at":"2018-01-31T01:58:24.000Z","date":"2018-01-26","kind":"sale","acquired":false,"shares":2607,"price":11.02,"value":28729.14,"ownership":{"direct":true},"balance_after":4893,"source":{"system":"sec-edgar","filing":"0000899243-18-002328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924318002328/doc4.xml","form_type":"4"}},{"id":4084576,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":169966,"kind":"person","name":"Trucksis Michele","position":1,"cik":"0001643736","reported_name":"Trucksis Michele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"COMMON STOCK","published_at":"2018-01-31T01:58:24.000Z","date":"2018-01-26","kind":"exercise","acquired":true,"shares":7500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."}],"balance_after":7500,"source":{"system":"sec-edgar","filing":"0000899243-18-002328","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924318002328/doc4.xml","form_type":"4"}},{"id":4478923,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":169966,"kind":"person","name":"Trucksis Michele","position":1,"cik":"0001643736","reported_name":"Trucksis Michele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and EVP"}}],"security":"Restricted Stock Units","published_at":"2017-01-27T22:51:29.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units vest as to 20% on January 26, 2018, 30% on January 26, 2019 and 50% on January 26, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units vest as to 20% on January 26, 2018, 30% on January 26, 2019 and 50% on January 26, 2020."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000899243-17-002121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924317002121/doc4.xml","form_type":"4"}},{"id":4478922,"issuer":{"id":7191,"kind":"organization","name":"Seres Therapeutics, Inc."},"owners":[{"id":169966,"kind":"person","name":"Trucksis Michele","position":1,"cik":"0001643736","reported_name":"Trucksis Michele","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer and EVP"}}],"security":"Stock Option (right to buy)","published_at":"2017-01-27T22:51:29.000Z","date":"2017-01-26","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as to 25% of the shares on January 26, 2018.  The remainder of the shares will vest in 12 equal quarterly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":9.89,"expiration_date":"2027-01-25","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000899243-17-002121","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609809/000089924317002121/doc4.xml","form_type":"4"}}]}